APPLICATION
ANDA077520
TYPE
ANDA
ORIGINAL APPROVAL
2006-04-14
LATEST ACTION
2024-07-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
LOVASTATINDiscontinued
LOVASTATIN 20MG · TABLET · ORAL
LOVASTATINDiscontinued
LOVASTATIN 40MG · TABLET · ORAL
LOVASTATINDiscontinued
LOVASTATIN 10MG · TABLET · ORAL
Approval history
2024-07-24Labeling · Supplement 15 · standardAP
2017-08-04Labeling · Supplement 14 · standardAP
2014-11-02Labeling · Supplement 10 · standardAP
2012-12-29Labeling · Supplement 9 · standardAP
2012-05-01Labeling · Supplement 8AP
2007-10-05Labeling · Supplement 4AP
2006-04-14OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.